# Wegovy maker Novo shares slump as management grilled on pricing, M&A

> **Open Intelligence Dossier** · First detected: 2026-09-21 17:00 UTC · Category: Business

## Executive Summary
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Wegovy maker Novo shares slump as management grilled on pricing, M&A" is generating significant coverage in the Business category, with 1 articles from 1 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Financial Times. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Telegraph India | Novo Nordisk targets more than five blockbuster drugs by 2030, CEO says | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxQNjhubFVqMzRLc2RRRDFjaVhBQUxvSnVjcFRpWmNmM0dnOXVxM0lmb3pBcTZxSEdTZUVzYnlyNFZZUlhtUVAwVjlRLS1DRlRUM24wTWl5cHN0d1hiRWhiaExYYnMxenFLU19TbTAzay1PWW91a1JfMnR1ZWZNWlRQWHAxb2t1c2gyQUlwcnFiVVB0NTYzdUFad0VHbUhiV0s5OVhRSzl4ODd5NWlBeTNLRHZrWkZmMW1HU0440gHAAUFVX3lxTE1nbmVRdGo5eWd0WXlXUGhZMjhuek9vSlNUQUdEQkx3b1J1QlFHOXVCS0p0U3RCdXBjSVFVaTk3dTZzZnZEQUNLdDRRM1JOYkF0dkRkNUVDTXNkeU5PZzFORzRYQmlfTERscmd4ZTY5d3NYazg1eGpISVpSVWhHSzRWNlMycHlZNlZIRmxHSHc4WmpQRFJmaWZ) |
| Financial Times | Novo’s prospects beyond weight-loss drugs look surprisingly lean | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxPSTlBTzBqUUU3N2kzNFgyWm9kMnFKM29WOFZVYl94X0Jub0VyME0xTmJXWURxcm92VUcxNVNiYklkNzVSTmdDVk1RUXAzZDlzSnpMNHlTVjBNbkJzYW5SQWxOMUdPQnM2a0V6VlZ2UVNlRF9uZU1fNC1uMkxKbUp3b3pwRnI?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-09-21/wegovy-maker-novo-shares-slump-as-management-grilled-on-pricing-m-a*